Skip to content

The good, the bad, and the intoxicated

Natasha Leigh Mason

2021 DOI: 10.26481/dis.20210608nm (opens in new tab)

Study at a glance

AI-extracted from the abstract
Characteristics Double-blind, placebo-controlled study
Sample size 20
Population Occasional cannabis users
Dose 300 μg/kg THC
Duration Two separate testing days
Measures magnetic resonance spectroscopy, functional magnetic resonance imaging
Topics Addiction Cannabis Psilocybin
Keywords Consciousness Drug Hallucinogen Recreational use
Key points THC increases striatal glutamate and reduces corticostriatal functional connectivity, correlating with subjective high and impaired attention.

Abstract

Cannabis is the most commonly used illicit drug and is known to alter state of consciousness and impair neurocognitive function. However, the mechanisms underlying these effects have yet to be fully elucidated. Rodent studies suggest that 9-tetrahydrocannabinol (THC) activates dopaminergic neurons in the limbic system, subsequently enhancing dopamine, which is implicated in the rewarding effects of cannabis. Additional evidence suggests that THC may act indirectly on dopamine firing by modulating GABA and glutamate release. This double-blind, placebo-controlled study assessed the acute influence of two doses of THC on brain kinetics of glutamate, GABA, and dopamine, in relation to behavioral outcomes, by using magnetic resonance spectroscopy and functional magnetic resonance imaging. Twenty occasional cannabis users received acute doses of cannabis (300 g/kg THC) and placebo, in one of two dose regimes (full dose and divided dose), during two separate testing days. Administration of THC increased striatal glutamate concentrations, and dopamine as indicated by a reduction in functional connectivity (FC) between the nucleus accumbens (NAc) and cortical areas. Alterations in glutamate and FC were dose dependent and evident in the full dose group where THC serum concentrations exceeded 2 ng/ml at T-max. Average glutamate changes correlated strongly with FC alterations. Additionally, THC induced changes in FC correlated with feelings of subjective high and decreased performance on an attention task. Taken together, this suggests that THC elicits subjective and cognitive alterations via increased striatal dopaminergic activity and loss of corticostriatal connectivity, which is associated with an increase in striatal glutamate.

Comparable studies

Other randomized controlled trials on cannabis for addiction, most cited first.

Study Year Design Participants
Psychedelic symptoms of cannabis and cocaine use as a function of trait impulsivity Regular drug users 2015 Three-way crossover study n = 122
The acute effects of cannabis, with and without cannabidiol, on attentional bias to cannabis related cues: a randomised, double-blind, placebo-controlled, cross-over study Adolescents (aged 16–17) and adults (aged 26–29) who used cannabis 0.5–3 days per week 2024 Randomized, double-blind, placebo-controlled, cross-over study n = 48
Individual and combined effects of Cannabidiol (CBD) and Δ9-tetrahydrocannabinol (THC) on striato-cortical connectivity in the human brain Healthy adults 2020 Randomized controlled trial n = 40
Brief report: The influence of childhood trauma on the effects of delta-9-tetrahydrocannabinol in persons with opioid use disorder. Persons receiving methadone for opioid use disorder 2024 Post-hoc analysis of a randomized, placebo-controlled, crossover trial n = 25
Value Signals Guiding Choices for Cannabis Versus Non-Drug Rewards in Regular Cannabis Users Near-daily cannabis users (≥4 days/week; non-treatment-seeking) 2023 Crossover experiment n = 21

Explore topics

By condition and practice